AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 66 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $74,286,965 | 86.51% |
| TFG Asset Management GP Ltd | 8,000,000 | $27,840,000 | 6.94% |
| STEMPOINT CAPITAL LP | 2,662,732 | $9,266,307 | 2.72% |
| Exome Asset Management LLC | 839,472 | $2,921,362 | 2.54% |
| GREAT POINT PARTNERS LLC | 3,441,667 | $11,977,001 | 2.29% |
| Affinity Asset Advisors, LLC | 4,300,000 | $14,964,000 | 1.72% |
| Deep Track Capital, LP | 15,272,172 | $53,147,159 | 1.59% |
| Frazier Life Sciences Management, L.P. | 4,623,324 | $16,089,168 | 0.75% |
| HighVista Strategies LLC | 518,820 | $1,805,494 | 0.66% |
| Avoro Capital Advisors LLC | 12,345,678 | $42,962,959 | 0.57% |